DESCRIPTION
TrastuRel (Trastuzumab) is a monoclonal antibody that is specifically designed to target HER2 receptors on breast cancer cells. It flags the cancer cells for destruction by the body’s immune system. TrastuRel is injected into a vein through an IV. It is a prescription drug.
Manufacturer : Reliance Life Science
SIDE EFFECTS
Most common side effects are Nausea, Headache, Rash, Reduced blood platelets, Congestive cardiac failure, Insomnia (difficulty in sleeping), Infection, Upper respiratory tract infection, Nasopharyngitis, Fatigue, Fever, Anemia, Chills, Diarrhoea, Cough, Weight loss, Altered taste, Mucosal inflammation, Decreased white blood cell count (neutrophils), Stomatitis (Inflammation of the mouth)
Reviews
There are no reviews yet.